Browse Drug Recalls
1,317 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 1,317 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 1,317 FDA drug recalls in IL.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Aug 27, 2014 | Hydrochloric acid/water for injection 10% (w/v) packaged in an amber glass dr... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Chorionic gonadotropin buffered diluent solution packaged in an amber glass i... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | PGE 20 mcg/mL injectable packaged in a clear glass injectable vial, Martin Av... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Tri-mix, 30 mg/3 mg/5 mcg/mL (papaverine, phentolamine mesylate, alprostadil)... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Testosterone cypionate 250 mg/mL injection packaged in an amber glass inject... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Tetracycline 250 mg powder kits packaged with powder and water in separate a... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Tacrolimus oil 0.03% opthalmic solution packaged in an opaque squeeze bottle ... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Sodium tetradecyl sulfate 1% (PF) injectable packaged in an amber glass injec... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Phenylephrine 1% injectable packaged in an amber glass injectable vial, Marti... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Tri-mix ST1, 30 mg/1.5 mg/50 mcg/mL (papaverine, phentolamine mesylate, alpro... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Lidocaine 1% injectable packaged in an amber glass injectable vial, Martin Av... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Alprostadil alcohol 500 mcg/mL injectable packaged in amber glass injectable ... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Quad mix, 30 mg/1 mg/20 mcg/0.15 mg/mL (papaverine, phentolamine mesylate, al... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Lidocaine (PF) 1% injectable packaged in an amber glass injectable vial, Mart... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Sodium tetradecyl sulfate 5% (PF) injectable packaged in an amber glass injec... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Hydromorphone HCl/bupivacaine (PF) 10 mg/7.5 mg/mL injection packaged in 30 m... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Morphine sulfate (PF) 3 mg/mL injectable packaged in 30 mL or 60 mL syringes,... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Quad mix, 30 mg/1 mg/10 mcg/0.15 mg/mL (papaverine, phentolamine mesylate, al... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Phenylephrine 10% opthalmic solution packaged in an opaque squeeze bottle eye... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Tri-mix ST9-B, 30 mg/2 mg/100 mcg/mL (papaverine, phentolamine mesylate, alpr... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Tri-mix, 30 mg/1 mg/20 mcg/mL (papaverine, phentolamine mesylate, alprostadil... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Methylcobalamin (PF) 1 mg/mL injectable packaged in an amber glass injectable... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Atropine sulfate 2 mg/mL injectable packaged in an amber glass injectable via... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Sodium tetradecyl sulfate 3% (PF) injectable packaged in an amber glass injec... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Hydromorphone HCl (PF) 1 mg/mL injectable packaged in 30 mL or 60 mL syringes... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Opthalmic ointment base ointment packaged in a white ointment tube, Martin Av... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Dexamethasone sodium phosphate 4 mg/mL injectable packaged in an amber glass ... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Methylcobalamin 1 mg/mL injectable packaged in an amber glass injectable vial... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Histamine 0.55 mg/mL injectable packaged in an amber glass injectable vial, M... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Atropine sulfate 0.01% opthalmic solution packaged in a squeeze bottle eye dr... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Rescue solution with triamcinolone (lidocaine, bupivacaine, heparin, triamcin... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Tri-mix ST2, 30 mg/3 mg/100 mcg/mL (papaverine, phentolamine mesylate, alpros... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Vancomycin 50 mg/mL opthalmic solution packaged in an opaque squeeze bottle e... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Tri-mix T50, 8.825 mg/0.29 mg/2.95 mcg/mL (papaverine, phentolamine mesylate,... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Chorionic gonadotropin/mannitol 10000 U/0.1 gm powder packaged in a white jar... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Methylcobalamin 25 mg/mL injectable packaged in an amber glass injectable via... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Phenol 10% injectable packaged in an amber glass injectable vial, Martin Aven... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Quad mix, 18 mg/0.2 mg/10 mcg/0.02 mg/mL (papaverine, phentolamine mesylate, ... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Quad mix 2, 12 mg/1 mg/25 mcg/0.25 mg/mL (papaverine, phentolamine mesylate, ... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Fentanyl injectable 6000 mcg/mL packaged in 30 mLor 60 mL syringes, Martin Av... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Voriconazole 10 mg/mL opthalmic solution packaged in an opaque squeeze bottle... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Hydroxyzine hydrochloride 25 mg/mL injectable packaged in an amber glass inje... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Benzalkonium chloride water for injection packaged in an amber glass injectab... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Hyaluronidase injection solution (PF) 150 U/mL injectable packaged in an ambe... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Quad mix, 9 mg/1 mg/10 mcg/0.1 mg/mL (papaverine, phentolamine mesylate, alpr... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 27, 2014 | Phentolamine mesylate 5 mg/35 mg/mannitol trituration packaged in a white jar... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of ... | Class II | Martin Avenue Pharmacy, Inc. |
| Aug 13, 2014 | PROPRANOLOL HYDROCHLORIDE INJECTION, USP 1 mg/mL, 1 mL Single Dose Vial, Rx o... | CGMP Deviations: Citations given to API supplier by the Italian Health Agency AIFA for several cr... | Class II | Fresenius Kabi USA, LLC |
| Aug 7, 2014 | Dianeal Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 2.5% Dextro... | Presence of Particulate Matter: particulate matter was found during the manufacturing process. | Class I | Baxter Healthcare Corp. |
| Aug 5, 2014 | Rifampin for Injection USP, 600 mg*/vial (Sterile), supplied in sterile glass... | Failed Impurity/Degradation Specification; high out of specification result for 23 transacetyl im... | Class III | Akorn, Inc. |
| Aug 4, 2014 | ProSol - sulfite-free (Amino Acid) Injection, 20%, 2000 mL VIAFLEX container ... | Presence of Particulate Matter: identification of particulates in a retention sample that have be... | Class II | Baxter Healthcare Corp |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.